Brevan Howard Capital Management’s AngioDynamics ANGO Stock Holding History

Brevan Howard Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$180K	Buy	+13,866	New	+$158K	﹤0.01%	1923
2026 Q1	–	Sell	-12,781	Closed	-$164K	–	2129
2025 Q4	$164K	Buy	+12,781	New	+$158K	﹤0.01%	1623
2024 Q4	–	Sell	-20,964	Closed	-$163K	–	1024
2024 Q3	$163K	Buy	20,964 +10,686	+104%	+$77.2K	﹤0.01%	1031
2024 Q2	$62.2K	Buy	+10,278	New	+$63.4K	﹤0.01%	998
2024 Q1	–	Sell	-19,048	Closed	-$149K	–	997
2023 Q4	$149K	Buy	+19,048	New	+$132K	﹤0.01%	916

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.7M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

WCM

Weber Capital Management San Francisco, California $118M AUM

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brevan Howard Capital Management's ANGO Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in AngioDynamics (ANGO) in Q2 2026: 13,866 shares worth $180K. The stake represents ﹤0.01% of the portfolio and ranks #1923 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in ANGO as recently as Q4 2025.

Brevan Howard Capital Management first reported a position in ANGO in Q4 2023 and has held it in 5 quarters since. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

Brevan Howard Capital Management held 13,866 shares of AngioDynamics worth $180K as of Q2 2026.
AngioDynamics was a new Brevan Howard Capital Management position in Q2 2026.
AngioDynamics made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1923 holding.
Brevan Howard Capital Management first reported a position in AngioDynamics in Q4 2023 and has held it in 5 quarters since.
161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.